BioForce Nanosciences Holdings, Inc. Announces the Appointment of Michael Dunham to Its Board of Directors
Published: Oct 01, 2007
AMES, Iowa, Oct. 1, 2007 (PRIME NEWSWIRE) -- BioForce Nanosciences Holdings, Inc. (OTCBB:BFNH), a company focused on the development and commercialization of nanotech tools and solutions for the life sciences, today announced the appointment of Michael Dunham to its Board of Directors. Mr. Dunham brings to BioForce his broad experience in high technology companies, which includes previously serving as a director for the nanotechnology company, Arryx Technology.